EB2 (MAPRE2) Human shRNA Plasmid Kit (Locus ID 10982)
CAT#: TF311571
MAPRE2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI1F3 (formerly 1F3)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | EB2 (MAPRE2) Human shRNA Plasmid Kit (Locus ID 10982) |
Locus ID | 10982 |
UniProt ID | Q15555 |
Synonyms | CSCSC2; EB1; EB2; RP1 |
Vector | pRFP-C-RS |
Format | Retroviral plasmids |
Kit Components | MAPRE2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 10982). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free. |
RefSeq | NM_001143826, NM_001143827, NM_001256420, NM_014268, NR_026570, NR_046177, NM_014268.1, NM_014268.2, NM_014268.3, NM_001143826.1, NM_001143826.2, NM_001143827.1, NM_001143827.2, NM_001256420.1, BC007318, BC007318.2, BM673789, NM_001256420.2, NM_014268.4, NM_001143827.3 |
Summary | The protein encoded by this gene shares significant homology to the adenomatous polyposis coli (APC) protein-binding EB1 gene family. This protein is a microtubule-associated protein that is necessary for spindle symmetry during mitosis. It is thought to play a role in the tumorigenesis of colorectal cancers and the proliferative control of normal cells. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2012] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
EB1- and EB2-dependent anterograde trafficking of TRPM4 regulates focal adhesion turnover and cell invasion
,Blanco, C;Morales, D;Mogollones, I;Vergara-Jaque, A;Vargas, C;Álvarez, A;Riquelme, D;Leiva-Salcedo, E;González, W;Morales, D;Maureira, D;Aldunate, I;Cáceres, M;Varela, D;Cerda, O;,
FASEB J.
,PubMed ID 31112396
[MAPRE2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...